738 related articles for article (PubMed ID: 12610518)
1. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
[TBL] [Abstract][Full Text] [Related]
2. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
3. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
4. Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure.
Koshikawa N; Iyozumi A; Gassmann M; Takenaga K
Oncogene; 2003 Oct; 22(43):6717-24. PubMed ID: 14555985
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.
Wild R; Dhanabal M; Olson TA; Ramakrishnan S
Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657
[TBL] [Abstract][Full Text] [Related]
6. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
Kim MS; Lee YM; Moon EJ; Kim SE; Lee JJ; Kim KW
Int J Cancer; 2000 Jul; 87(2):269-75. PubMed ID: 10861486
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
11. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
12. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
[TBL] [Abstract][Full Text] [Related]
13. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
Udagawa T; Yuan J; Panigrahy D; Chang YH; Shah J; D'Amato RJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):421-7. PubMed ID: 10900214
[TBL] [Abstract][Full Text] [Related]
14. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
Liu N; Lapcevich RK; Underhill CB; Han Z; Gao F; Swartz G; Plum SM; Zhang L; Green SJ
Cancer Res; 2001 Feb; 61(3):1022-8. PubMed ID: 11221828
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
[TBL] [Abstract][Full Text] [Related]
16. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
[TBL] [Abstract][Full Text] [Related]
18. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M
Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]